I think we're close to a turn around. Q1 is finished and now for company targets in Q2, specifically the commercialization phase of the cream. I think we may hear more about the sublingual tablet since they also want to get that on the market to this year.
I'm in higher myself, like you, but I'm not going to worry. This is not a short term play and by the end of the year I think we will be pleasantly surprised.
(3)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links